New sedative may offer safer heart scans
NCT ID NCT06129188
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new FDA-approved sedative, remimazolam, against the standard drug propofol for people having a heart ultrasound called TEE. The goal was to see if remimazolam keeps blood pressure and heart rate more stable. 105 adults took part, and researchers measured vital signs and sedation levels during the procedure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANESTHESIA are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Alabama at Birmingham Hospital
Birmingham, Alabama, 35233, United States